Business Context and Reporting Period
This Form 8-K reports on the 2016 Annual Meeting of Stockholders held on June 9, 2016. The registrant is Catalyst Biosciences, Inc. (formerly Targacept, Inc.), a Delaware corporation. The filing details the results of stockholder votes and the approval of amendments to the company's stock incentive plan.
Key Financial Metrics
This filing is a current report regarding corporate governance and stockholder actions. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metrics.
Material Changes and Voting Results
At the Annual Meeting, 9,048,081 shares were represented, constituting 79.2% of outstanding shares and a quorum. The following material actions were approved:
- Stock Incentive Plan Amendment: Stockholders approved an amendment to the 2015 Stock Incentive Plan, increasing the number of shares available for issuance by 1,000,000 and modifying minimum one-year vesting requirements.
- Election of Directors: Stephen A. Hill, M.D., and Augustine Lawlor were elected as Class I directors for a three-year term.
- Executive Compensation: The "Say on Pay" advisory vote was approved.
- Auditor Ratification: The appointment of EisnerAmper LLP as the independent registered public accounting firm for fiscal year 2016 was ratified.
Guidance, Outlook, and Risks
The filing does not contain management commentary on future guidance, outlook, risks, contingencies, or unusual items. The document focuses strictly on the procedural outcomes of the Annual Meeting.
Investor Verification Checklist
- Verify the full text of the amended 2015 Stock Incentive Plan (Exhibit 10.1) to understand the specific changes to vesting requirements.
- Confirm the total number of shares authorized under the plan post-amendment by reviewing the definitive proxy statement filed on April 25, 2016.
- Review the voting breakdown for the "Say on Pay" proposal to assess stockholder sentiment regarding executive compensation.
- Check subsequent filings for the impact of the new auditor appointment on the 2016 fiscal year audit process.